HEALTHPEAK PROPERTIES, INC.
No SEC Form 4 filings for $DOC in the last 30 days.
See all $DOC insider activity →Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.
DO & CO reported Q1 FY26/27 results despite Middle East headwinds. Sales rose 5% to €642m and EBIT rose 8% to €57m, margin 8.8%. Net profit increased 16% to €31m. Management said conflict-related costs reduced sales by about €40m. FY26/27 targets are 6-8% sales growth with EBIT margin 8.6-9.0%.
Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning DOC (HEALTHPEAK PROPERTIES, INC.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent DOC coverage spans earnings, mergers & acquisitions and sector analysis.
Guidance lift suggests stronger earnings outlook, likely supporting the stock.
Resilient Q1 results with margin improvement and a clear FY 26/27 acceleration plan (Heathrow step-up, additional contract starts).
The call highlights improving lab occupancy and active capital recycling, supporting near-term NOI visibility while keeping leverage and execution risk in focus.
The earnings beat and reiterated full-year FFO range are the core near-term catalyst for DOC, supporting a bullish bias versus Street expectations.
The filing is primarily metric methodology, not new operating results or guidance, so near-term price impact is likely limited.
AlphAI scores every news story that mentions DOC with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHPEAK PROPERTIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Healthpeak Properties (DOC) raised its 2026 guidance, citing strong performance in outpatient medical and lab leasing, and significant growth at its senior housing operator, Janus Living (JAN). The company reported $0.46 FFO per share, flat year-over-year, and used asset sales to reduce debt and fund buybacks. Lab segment NOI declined, and leverage remains at 4.7x EBITDAre.
3 min readDO & CO reported Q1 FY26/27 results despite Middle East headwinds. Sales rose 5% to €642m and EBIT rose 8% to €57m, margin 8.8%. Net profit increased 16% to €31m. Management said conflict-related costs reduced sales by about €40m. FY26/27 targets are 6-8% sales growth with EBIT margin 8.6-9.0%.
4 min readHealthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.
6 min readHealthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.
3 min readHEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Healthpeak Properties Reports Second Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance DENVER, August 4, 2026 - Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery
2 min readBrookfield Asset Management and its affiliates formed a joint venture with Healthpeak Properties to obtain a 49% interest in Healthpeak’s 86 outpatient medical buildings nationwide, valued at about $2.1B. The portfolio totals about 5.6M sq ft across 11 states and is 95% leased, per the announcement. Healthpeak keeps 51% control and received about $1B in gross proceeds.
4 min readBrookfield Asset Management will form a U.S. outpatient medical buildings joint venture with Healthpeak Properties. Healthpeak will contribute 86 properties valued at about US$2.1 billion. Brookfield and affiliates will hold 49% and receive about US$1.03 billion in gross proceeds, while Healthpeak holds 51% and manages. The portfolio is 95% leased across 11 states.
2 min readHealthpeak Properties (DOC) is set to report fiscal Q2 2026 results after the close Aug. 4. Analysts expect adjusted FFO of $0.44 per share, down from $0.46 a year earlier. For fiscal 2026, consensus calls for adjusted FFO of $1.75 per share. The stock is rated “Moderate Buy” with a $21.71 average target.
2 min readScotiabank raised its price target for Healthpeak Properties (NYSE:DOC) from $19.00 to $21.00 and kept a “sector perform” rating, implying about 4.19% upside from the prior close, according to the note reported by Benzinga. The article also cites other analyst target changes and notes DOC traded at $20.16 on Wednesday.
2 min readInvesco’s SPHD ETF targets the S&P 500’s highest-dividend stocks, then selects the 50 lowest realized-volatility names and weights by yield. Over five years, SPHD returned 36% total (~6% annualized) versus SPY’s 92% with dividends reinvested. The article cites SPHD’s 4.5% monthly yield and higher 0.30% fee, arguing alternatives like Schwab’s SCHD (0.06% fee, 53% five-year return) have outperformed.
6 min read
